Journal article

Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD >= 15)

GW McCaughan, PA Thwaites, SK Roberts, SI Strasser, J Mitchell, B Morales, S Mason, P Gow, A Wigg, C Tallis, G Jeffrey, J George, AJ Thompson, FC Parker, PW Angus

Alimentary Pharmacology & Therapeutics | WILEY | Published : 2018